Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A
PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934
Filed
by the Registrant ☑
Filed
by a Party other than the Registrant ☐
Check
the appropriate box:
|
☐
|
Preliminary
Proxy Statement
|
|
☐
|
Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
|
|
☑
|
Definitive
Proxy Statement
|
|
☐
|
Definitive
Additional Materials
|
|
☐
|
Soliciting
Material Pursuant to Section 240.14a-12
|
YOUNGEVITY INTERNATIONAL, INC.
(Name of Registrant as Specified in Its Charter)
(Name of Person(s) Filing Proxy Statement, if Other Than the
Registrant)
Payment
of Filing Fee (check the appropriate box):
|
☑
|
No fee
required.
|
|
☐
|
Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and
0-11.
|
|
|
(1)
|
Title
of each class of securities to which transaction
applies:
|
|
|
(2)
|
Aggregate
number of securities to which transaction applies:
|
|
|
(3)
|
Per
unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (Set forth the amount on which
the filing fee is calculated and state how it was
determined):
|
|
|
(4)
|
Proposed
maximum aggregate value of transaction:
|
|
|
(5)
|
Total
fee paid:
|
|
☐
|
Fee
paid previously with preliminary materials.
|
|
☐
|
Check
box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by
registration statement number, or the Form or Schedule and the date
of its filing.
|
|
|
(1)
|
Amount
Previously Paid:
|
|
|
(2)
|
Form,
Schedule or Registration Statement No.:
|
|
|
(3)
|
Filing
Party:
|
|
|
(4)
|
Date
Filed:
|
2400
Boswell Road
Chula
Vista, California 91914
(619)
934-3980
June 8,
2018
Dear
fellow Youngevity International, Inc. Stockholders,
We are
pleased to provide you with an update on our progress over the last
year and recent months and to let you know that we are continuing
to significantly improve the way we communicate with you, our
stockholders.
In case
you missed it, last year we reached a record year in revenues,
which were up 1.9% to $165,696,000 as compared to $162,667,000 in
the prior year. Revenues for the fourth quarter ended December 31,
2017 increased 6.9% to $41,041,000 as compared to $38,403,000 for
the fourth quarter in the prior year
During
our recent first quarter of 2018, we announced that revenues
increased 11% to $42,994,000 for the quarter ended March 31, 2018
compared to $38,733,000 for the same period last year. We
derived approximately 82% of our revenue from direct selling
segment sales and approximately 18% from commercial coffee segment
sales. Direct selling revenues increased by $2,069,000 or 6.2% to
$35,311,000 as compared to $33,242,000 for the same period last
year. Commercial coffee revenues increased by $2,192,000 or 39.9%
to $7,683,000 as compared to $5,491,000 for the same period last
year.
Overall
gross profit during the quarter ended March 31, 2018 increased
14.4% to $25,012,000 as compared to $21,866,000 for the same period
last year. Overall gross profit as a percentage of revenues
increased to 58.2%, during the quarter ended March 31, 2018
compared to 56.5% in the same period last year.
Total
operating expenses during the quarter ended March 31, 2018
increased 3.0% to $24,988,000 as compared to $24,266,000 for the
same period last year.
During
the first quarter of 2018 we also completed our offering of a
Series B Convertible Preferred Stock in which we raised aggregate
proceeds of $3,621,143.
CLR
Roasters, our wholly-owned subsidiary and commercial coffee
segment, is expected to continue on a rapid growth trajectory this
year. We are enthusiastic about the revenue growth of our company
owned retail and food service brand Café La Rica. Since our
Café La Rica brand became “the Official Cafecito of the
Miami Marlins" our growth has been accelerating, including our
expansion into the Bravo Supermarkets and Sabor Tropical
Supermarkets. During the first quarter of 2018, as a result of the
increase in brand name exposure, we sold 407,049 retail brick packs
to consumers as compared to 125,340 retail brick packs for the same
period in 2017, representing a 224% growth.
Our
Café La Rica brand has seen a similar expansion in food
service sales business, which represents the highest margin portion
of our coffee business. During the first quarter of 2018, we
generated $145,363 in food service sales, compared to $46,619 when
compared to the same quarter in the prior year, representing 211%
growth. Overall, the commercial coffee segment of Youngevity posted
39.9% revenue growth when compared to the prior year
quarter.
With
the Café La Rica brand, we have full field-to-cup
capabilities, meaning Youngevity through CLR Roasters; grows,
produces, packages, and sells its own organic, fair trade and
sustainable certified coffee. We own the entire production process
from the farm to the cup, and we’re actively working with a
number of large distributors to get some of the freshest coffee on
the market into more cups around the world.
We
recently completed plant automation on a single serve production
line by adding a fully automated and versatile robotic box assembly
and packaging system. This new technology greatly expands
production capacity and is expected to provide significant
efficiency gains and cost benefits to our single serve production
line. The Italian designed and manufactured, fully automated
robotic system enables us to automatically produce cartons and pack
out single serve cups in multiple configurations including 8, 10,
12, 18 and 24 count boxes and additionally is able to pack up to 80
count bulk pack configurations.
Our
leading omni-direct lifestyle company, offering a hybrid of the
direct selling business model that leverages e-commerce and the
power of social selling, continues to build strength. We recently
hosted a sales convention in May in Malaysia that was widely
attended by distributors from eight (8) Asian countries including
Hong Kong, Indonesia, Japan, Malaysia, Singapore, Philippines,
Brunei and Taiwan.
We are
still actively pursuing acquisitions, and in March we acquired
Doctor's Wellness Solutions Global LP, the distributors of
ViaViente, a highly-concentrated, energizing whole fruit puree
blend that is rich in antioxidants and naturally-occurring vitamins
and minerals. ViaViente was introduced to the public in 2003,
following years of research that included studies of mineral rich
waters whose source is found in the Andes Mountains and flow thru
Vilcabamba, Ecuador, a region known for its high concentration of
centenarians. In 2007 ViaViente became the first product in the
market to receive the coveted Brunswick Labs ORAC Seal of
Certification for its antioxidant content.
In February, we acquired Nature Direct, an Australian company
formed in 2007 to create eco-friendly, effective, and affordable
home cleaning products using essential-oils. Since then, the
company has grown its product lines to include personal care and
professional use non-toxic disinfectant products. Until now, Nature
Directs’ sales force has been located in and focused on
solely the Australian market. After being integrated into
Youngevity, their products are now made available throughout our
social selling program that operates in seven (7) countries
including New Zealand, Mexico, Colombia, and the United
States.
We are
pleased to see our direct selling segment stabilizing its organic
growth, which has been a challenge over the last couple of years.
Our international market expansion is now contributing to revenue
and the overall growth of Youngevity, and this has been a sizeable
investment over the last several years. To see these markets’
revenue growth and performance is encouraging.
Our
acquisition strategy of overlaying accretive revenue on top of
in-place infrastructure is proving to be effective. The Nature
Direct acquisition is contributing nicely to our Australia and New
Zealand growth and profitability and we expect to integrate their
line of healthier cleaning products in the United States and to
introduce these products at our August 2018 Annual Convention in
San Diego. Similarly, the acquisition of Doctor's Wellness
Solutions Global LP is driving a nice increase in Japan and a major
driver of our growth in Asia. Japan has quickly become a profitable
market for our company.
In closing, we want to let you know that we have embarked upon a
new and exciting identity and branding initiative. We’re in
the process of engaging support for investor relations and brand
awareness. These strategies will guide us as we refine our message
and build upon our investor awareness and market visibility. The
initial work will include the development of a new investor
relations web portal, enhanced social media and email-based
investor connections. We intend to provide updates over the course
of the year and intend to share broader insight into what we are
doing as a business.
We
would like to thank our stockholders for your continued support and
we look forward to keeping you informed of further developments as
we progress.
Thank
you,
|
/s/ Stephan
Wallach
|
|
Stephan
Wallach
Chief
Executive Officer
|
/s/ David Briskie
David
Briskie
President
& Chief Financial Officer
2400
Boswell Road
Chula
Vista, California 91914
(619)
934-3980
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
To be
held on July 23, 2018
To the
Stockholders of Youngevity International, Inc.:
We
hereby notify you that the 2018 Annual Meeting (the “2018
Annual Meeting” or “Annual Meeting”) of
stockholders of Youngevity International, Inc., a Delaware
corporation, will be held on Monday, July 23, 2018 beginning at
9:00 a.m., Pacific Daylight Time, at our corporate office located
at 2400 Boswell Road, Chula Vista, California 91914, for the
following purposes:
|
|
(1)
|
to
elect the seven (7) nominees for director named herein to our Board
of Directors (the “Board” or “Board of
Directors”) to hold office until our next annual meeting of
stockholders and until their successors are duly elected and
qualified;
|
|
|
(2)
|
to
ratify the appointment of Mayer Hoffman McCann P.C. as our
independent registered public accounting firm for our fiscal year
ending on December 31, 2018; and
|
|
|
(3)
|
to
transact such other business as may properly come before the
meeting or any adjournments or postponements of the
meeting.
|
The
matters listed in this notice of meeting are described in detail in
the accompanying proxy statement. Our Board of Directors has fixed
the close of business on May 30, 2018 as the record date for
determining those stockholders who are entitled to notice of and to
vote at the 2018 Annual Meeting or any adjournment or postponement
of our 2018 Annual Meeting. The list of the stockholders of record
as of the close of business on May 30, 2018 will be made available
for inspection at the meeting.
IMPORTANT
NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL
MEETING OF STOCKHOLDERS TO BE HELD ON JULY 23, 2018
THE PROXY MATERIALS OF ANNUAL MEETING OF
STOCKHOLDERS, INCLUDING THE PROXY STATEMENT AND OUR ANNUAL REPORT
ON FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2017 ARE AVAILABLE
ELECTRONICALLY AT WWW.YGYI.COM.
On or
about June 15, 2018, we will begin mailing the attached Proxy
Statement and our Annual Report on Form 10-K for the year ended
December 31, 2017. Such annual report includes our audited
financial statements.
YOUR VOTE IS IMPORTANT
Even if
you plan to attend the meeting, please vote as promptly as possible
by using the internet or kindly sign, date, and return the enclosed
proxy card in the envelope provided so that your vote will be
counted if you later decide not to attend the 2018 Annual Meeting.
No postage is required if the proxy card is mailed in the United
States.
By
Order of the Board of Directors,
/s/ Stephan
Wallach
Stephan
Wallach
Chairman of the
Board and CEO
Chula Vista,
CA
June 8,
2018
|
2400
Boswell Road
Chula
Vista, California 91914
(619)
934-3980
PROXY
STATEMENT
This
Proxy Statement is being furnished to holders of shares of common
stock, $0.001 par value per share, of Youngevity International,
Inc., a Delaware corporation (“we,” us,”
“YGYI,” or the “Company”), in connection
with the solicitation of proxies on behalf of our Board of
Directors for use at our 2018 Annual Meeting of Stockholders (the
“2018 Annual Meeting”) to be held on July 23, 2018 at
9:00 a.m. (Pacific Daylight Time), at our corporate office located
at 2400 Boswell Road, Chula Vista, California 91914, and at any
adjournment or postponement of our 2018 Annual Meeting. The purpose
of the 2018 Annual Meeting and the matters to be acted on are
stated in the accompanying notice of the 2018 Annual Meeting. The
Board of Directors knows of no other business that will come before
the 2018 Annual Meeting of Stockholders.
The
notice of our 2018 Annual Meeting, this Proxy Statement, and a
proxy card, together with our Annual Report on Form 10-K for the
year ended December 31, 2017, are being mailed to our stockholders
on or about June 15, 2018. Such annual report, which includes our
audited financial statements, is not to be regarded as proxy
solicitation material. We will bear the cost of our solicitation of
proxies. The original solicitation of proxies by mail may be
supplemented by personal interview, telephone, or facsimile by our
directors, officers, or employees, who will receive no additional
compensation for such services. Arrangements will be made with
brokerage houses and other custodians, nominees, and fiduciaries
for the forwarding of solicitation material to the beneficial
owners of stock held by any such persons, and we will reimburse
those custodians, nominees, and fiduciaries for the reasonable
out-of-pocket expenses incurred by them in doing so.
Our
Board of Directors is soliciting votes FOR each of the seven (7) nominees named
herein for election to our Board of Directors; and FOR the ratification of the appointment
of Mayer Hoffman McCann P.C. as our independent registered public
accounting firm for the year ending December 31, 2018.
|
|
INFORMATION ABOUT VOTING
|
Q:
|
Why did I receive these proxy materials?
|
|
|
|
|
A:
|
The
Board of Directors is providing these proxy materials to you in
connection with our 2018 Annual Meeting of Stockholders, which is
scheduled to take place on July 23, 2018. As a stockholder of
record as of May 30, 2018, you are invited to attend the 2018
Annual Meeting and to vote on the items of business described in
this Proxy Statement.
|
|
|
|
|
Q:
|
What information is contained in the proxy statement?
|
|
|
|
|
A:
|
The
information included in this proxy statement relates to the
proposals to be voted on at the 2018 Annual Meeting, the voting
process, the compensation of our directors and executive officers,
and other required information.
|
|
|
|
|
Q:
|
What items of business will be voted on at the 2018 Annual
Meeting?
|
|
|
|
|
A:
|
The two
(2) items of business scheduled to be voted on at the 2018 Annual
Meeting are: (1) the election of our directors; and (2) the
ratification of Mayer Hoffman McCann P.C. as our independent
registered public accounting firm for our fiscal year ending on
December 31, 2018.
|
|
|
|
|
Q:
|
How does the Board of Directors recommend that I vote?
|
|
|
|
|
A:
|
The
Board of Directors recommends that you vote your shares (1)
FOR each of the nominees
named herein for election to our Board of Directors; and (2)
FOR the ratification of the
appointment of Mayer Hoffman McCann P.C. as our independent
registered public accounting firm for our fiscal year ending on
December 31, 2018.
|
|
|
|
|
Q:
|
What shares can I vote?
|
|
|
|
|
A:
|
You may
vote or cause to be voted all shares owned by you as of the close
of business on May 30, 2018, the record date. These shares include:
(1) shares held directly in your name as a stockholder of record;
and (2) shares held for you, as the beneficial owner, through a
broker or other nominee, such as a bank.
|
|
|
|
|
Q:
|
What is the difference between holding shares as a stockholder of
record and as a beneficial owner?
|
|
|
|
|
A:
|
Some of
our stockholders may hold their shares through a broker or other
nominee rather than directly in their own name. As summarized
below, there are some distinctions between shares held of record
and those owned beneficially.
|
|
|
|
|
|
Record Holder. If your shares are registered directly in
your name on the books of YGYI maintained with our transfer agent,
Pacific Stock Transfer Company, you are considered the
“record holder” of those shares, and the proxy
materials are sent directly to you by YGYI. As the stockholder of
record, you have the right to grant your voting proxy directly or
to vote in person at the meeting.
Beneficial Owner of Shares Held in Street Name. If your shares are
held in a stock brokerage account or by a bank or other nominee,
you are considered the “beneficial owner” of shares
held in street name (also called a “street name”
holder), and the proxy materials will be forwarded to you by your
broker, bank or other nominee. As a beneficial owner, you have the
right to direct your broker, bank or other nominee on how to vote
the shares held in your account. However, since you are not a
stockholder of record, you may not vote these shares in person at
the 2018 Annual Meeting unless you bring with you a legal proxy
from the stockholder of record. A legal proxy may be obtained from
your broker, bank or nominee. If you do not wish to vote in person
or you will not be attending the 2018 Annual Meeting, you may vote
by following the instructions, or if you request printed proxy
materials, you will receive voting instructions from your broker,
bank or nominee describing the available processes for voting your
stock.
Broker Non-Votes; Routine Matters. If you hold your shares
through a broker and you do not give instructions to the record
holder on how to vote, the record holder will be entitled to vote
your shares in its discretion on the matter considered routine,
which is the ratification of the appointment of independent
auditors. The uncontested election of directors is not considered a
routine matter. Therefore, brokers do not have the discretion to
vote on the election of directors. If you hold your shares in
street name and you do not instruct your broker how to vote on
Proposal 1, which is not considered a routine matter, no votes will
be cast by your broker on your behalf. These “broker
non-votes” will be treated as shares that are present and
entitled to vote for purposes of determining the presence of a
quorum, but not as shares entitled to vote on a particular
proposal.
|
|
Q:
|
May I attend the 2018 Annual Meeting?
|
|
|
|
|
A.
|
You
are
entitled to attend the 2018 Annual Meeting only if you were a
stockholder as of the close of business on the record date, May 30,
2018, or you hold a valid proxy for the 2018 Annual Meeting of
Stockholders. You should be prepared to present photo
identification for admittance and evidence of your share ownership
of our common stock on the record date. If you are not a record
holder but hold shares beneficially through a broker or nominee
(that is, in “street name”), you should provide proof
of beneficial ownership on the record date, such as your most
recent account statement, or other similar evidence of ownership, a
copy of the voting instruction card provided by your broker or
nominee. If you do not provide photo identification or comply with
the other procedures outlined above upon request, you may not be
admitted to the 2018 Annual Meeting. The 2018 Annual Meeting will
begin promptly at 9:00 a.m. (Pacific Daylight Time). Check-in will
begin at 8:30 a.m., and you should allow ample time for the
check-in procedures.
|
|
|
|
|
Q:
|
How can I vote my shares in person at the 2018 Annual Meeting of
Stockholders?
|
|
|
|
|
A:
|
You may
vote by ballot in person at the 2018 Annual Meeting any shares that
you hold as the stockholder of record. You may only vote in person
shares held in street name if you obtain from the broker or nominee
that holds your shares a valid proxy giving you the right to vote
the shares.
|
|
|
|
|
Q:
|
How can I vote my shares without attending the 2018 Annual
Meeting?
|
|
|
|
|
A:
|
Whether
you hold shares directly as the stockholder of record or
beneficially in street name, you may, without attending the
meeting, direct how your shares are to be voted.
|
|
|
|
|
|
Stockholder of Record — Shares Registered in Your
Name: If you are a stockholder of record, in addition to
voting in person at the 2018 Annual Meeting, you may vote by proxy
through the internet, or vote by proxy using a proxy card. Whether
or not you plan to attend the 2018 Annual Meeting, we urge you to
vote by proxy to ensure your vote is counted. You may still attend
the meeting and vote in person even if you have already voted by
proxy.
|
|
|
● Vote by
Internet, by going
to the web address www.voteproxy.com and following the instructions
for internet voting shown on your proxy card. Your Internet vote
must be received by 11:59 p.m., Eastern Daylight Time, on July 22,
2018 to be counted.
|
|
|
|
|
|
● Vote by Proxy Card,
by completing, signing, dating and mailing the enclosed proxy card
in the envelope provided. If you return your signed proxy card to
us before the 2018 Annual Meeting, we will vote your shares as you
direct. If you vote by internet, please do not mail your proxy
card.
|
|
|
|
|
|
Beneficial Owner — Shares Registered in the Name of a Broker or
Bank: If you are a beneficial owner of shares registered in
the name of your broker, bank, or other agent, you should have
received an instruction card containing voting instructions from
that organization rather than from us. Simply follow the voting
instructions in the voting instruction card to ensure that your
vote is counted.
|
|
We provide internet proxy voting to allow you to
vote your shares online, with procedures designed to ensure
authenticity and correctness of your proxy vote instructions.
Please be aware, however, that you must bear any costs associated
with your internet access, such as usage charges from internet
access providers and telephone companies.
|
|
Q:
|
Can I change my vote or revoke my proxy?
|
|
|
|
|
A:
|
You may
change your vote or revoke your proxy at any time before the final
vote at the 2018 Annual Meeting. To change your vote or revoke your
proxy if you are the record holder, you may: (1) notify our
Corporate Secretary in writing at Youngevity International, Inc.,
2400 Boswell Road, Chula Vista, California 91914; (2) submit a
later-dated proxy (either by mail or internet), subject to the
voting deadlines that are described on the proxy card or voting
instruction form, as applicable; (3) deliver to our Corporate
Secretary another duly executed proxy bearing a later date; or (4)
by appearing at the 2018 Annual Meeting in person and voting your
shares. Attendance at the meeting will not, by itself, revoke a
proxy unless you specifically so request.
For
shares you hold beneficially, you may change your vote by
submitting new voting instructions to your broker or nominee or, if
you have obtained a valid proxy from your broker or nominee giving
you the right to vote your shares, by attending the 2018 Annual
Meeting and voting in person. You may also change your vote by
sending a written notice of revocation to our Corporate Secretary
in writing at Youngevity International, Inc., 2400 Boswell Road,
Chula Vista, California 91914.
|
|
|
|
|
Q:
|
Who can help answer my questions?
|
|
|
|
|
A:
|
If you
have any questions about the 2018 Annual Meeting or how to vote or
revoke your proxy, or you need additional copies of this proxy
statement or voting materials, you should contact the Corporate
Secretary, Youngevity International, Inc., 2400 Boswell Road, Chula
Vista, California 91914 or by phone at (619) 934-3980.
|
|
|
|
|
Q:
|
How are votes counted?
|
|
|
|
|
A:
|
In the
election of directors, you may vote FOR all of the seven (7) nominees named
herein or you may direct your vote to be WITHHELD with respect to
any one or more of the seven (7) nominees.
|
|
|
|
|
|
With
respect to Proposal 2, you may vote FOR, AGAINST, or ABSTAIN. On this proposal, if you
ABSTAIN, it has the same
effect as a vote AGAINST.
|
|
|
|
|
If you
provide specific instructions, your shares will be voted as you
instruct. If you sign your proxy card or voting instruction card
with no further instructions, your shares will be voted in
accordance with the recommendations of the Board of Directors,
namely (1) FOR each of the
seven (7) nominees named herein for election to our Board of
Directors; and (2) FOR the
ratification of Mayer Hoffman McCann P.C. as our independent
registered public accounting firm for the year ending December 31,
2018. If any other matters properly arise at the meeting, your
proxy, together with the other proxies received, will be voted at
the discretion of the proxy holders.
|
|
|
|
|
Q:
|
What is a quorum and why is it necessary?
|
|
|
|
|
A:
|
Conducting
business at the meeting requires a quorum. The presence, either in
person or by proxy, of the holders of a majority of our shares of
common stock outstanding on May 30, 2018 is necessary to constitute
a quorum. Abstentions are treated as present for purposes of
determining whether a quorum exists. Your shares will be counted
towards the quorum only if you submit a valid proxy (or one is
submitted on your behalf by your broker, bank or other nominee) or
if you vote in person at the 2018 Annual Meeting. Broker non-votes
(which result when your shares are held in “street
name” and you do not tell the nominee how to vote your shares
on a non-routine matter) are treated as present for purposes of
determining whether a quorum is present at the meeting. If there is
no quorum, the stockholders present at the meeting in person or
represented by proxy may by majority vote adjourn the meeting to
another date.
|
|
|
|
|
Q:
|
What is the voting requirement to approve each of the
proposals?
|
|
|
|
|
A:
|
For
Proposal 1 (the election of directors), the seven (7) persons named
herein receiving the highest number of FOR votes (from the holders of votes of
shares present in person or represented by proxy at the 2018 Annual
Meeting and entitled to vote on the election of directors) will be
elected. Only votes FOR or
WITHHELD will affect the
outcome. Abstentions and broker non-votes will have no effect on
the outcome of the vote as long as each nominee receives at least
one FOR vote. You do not
have the right to cumulate your votes.
|
|
|
|
|
|
To be
approved, Proposal 2 (ratification of the appointment of Mayer
Hoffman McCann P.C., as our independent registered public
accounting firm for the year ending December 31, 2018) must receive
the affirmative vote from the holders of a majority of those shares
present in person or represented by proxy and entitled to vote on
that proposal at the 2018 Annual Meeting. Accordingly, abstentions
on these proposals will have the same effect as a vote against the
proposal. Broker non-votes (although none are expected to exist in
connection with Proposal 2) will have no effect on these proposals.
Proposal 2 is an advisory vote, and therefore is not binding on us,
the Audit Committee of our Board of Directors (the “Audit
Committee”) or our Board of Directors. If our stockholders
fail to ratify the appointment, the Audit Committee will reconsider
whether or not to retain that firm. Even if the appointment is
ratified, the Audit Committee in its discretion may direct the
appointment of different independent auditors at any time during
the year if they determine that such a change would be in the best
interests of YGYI and its stockholders.
|
|
|
|
|
|
If your
shares are held in “street name” and you do not
indicate how you wish to vote, your broker is permitted to exercise
its discretion to vote your shares on certain “routine”
matters. The only routine matter to be submitted to our
stockholders at the 2018 Annual Meeting is Proposal 2. Proposals 1
is not a routine matter. Accordingly, if you do not direct your
broker how to vote for a director in Proposal 1, your broker may
not exercise discretion and may not vote your shares on that
proposal.
For
purposes of Proposal 1, broker non-votes are not “entitled to
vote” at the meeting unless otherwise instructed. As such, a
broker non-vote will not be counted as a vote FOR or WITHHELD with respect to a director in
Proposal 1, Abstentions will be counted in determining the total
number of “votes cast” and the total number of shares
present in person or represented by proxy and entitled to vote on
each of the proposals and will therefore have the effect of a vote
AGAINST on each proposal,
except for Proposal 1, where the abstention will have no effect on
the outcome of the vote.
We
encourage you to vote FOR
both Proposals.
|
|
|
|
|
Q:
|
What should I do if I receive more than one set of voting
materials?
|
|
|
|
|
A:
|
You may
receive more than one set of voting materials, including multiple
copies of this Proxy Statement and multiple proxy cards or voting
instruction cards. For example, if you hold your shares in more
than one brokerage account, you will receive a separate voting
instruction card for each brokerage account in which you hold
shares. If you are a stockholder of record and your shares are
registered in more than one name, you will receive more than one
proxy card. Please complete, sign, date, and return each proxy card
and voting instruction card that you receive.
|
|
|
|
|
Q:
|
Where can I find the voting results of the 2018 Annual
Meeting?
|
|
|
|
|
A:
|
We
intend to announce preliminary voting results at the 2018 Annual
Meeting and publish final results in a Current Report on Form 8-K,
which will be filed within four (4) business days of the 2018
Annual Meeting. If final voting results are not available to us in
time to file a Current Report on Form 8-K within four (4) business
days after the 2018 Annual Meeting, we intend to file a Current
Report on Form 8-K to publish preliminary results and, within four
(4) business days after the final results are known to us, file an
additional Current Report on Form 8-K to publish the final
results.
|
|
|
|
|
Q:
|
What happens if additional matters are presented at the 2018 Annual
Meeting?
|
|
|
|
|
A:
|
Other
than the two (2) items of business described in this proxy
statement, we are not aware of any other business to be acted upon
at the 2018 Annual Meeting. If you grant a proxy, the persons named
as proxy holders, Mr. Stephan Wallach, our Chief Executive Officer
and Mr. David Briskie, our President and Chief Financial Officer,
will have the discretion to vote your shares on any additional
matters properly presented for a vote at the meeting. If for any
unforeseen reason any of our nominees are not available as a
candidate for director, the persons named as proxy holders will
vote your proxy for any one or more other candidates nominated by
the Board of Directors.
|
|
|
|
|
Q:
|
How many shares are outstanding and how many votes is each share
entitled?
|
|
|
|
|
A:
|
Each
share of our common stock that is issued and outstanding as of the
close of business on May 30, 2018, the record date, is entitled to
be voted on all items being voted on at the 2018 Annual Meeting,
with each share being entitled to one vote on each matter. As of
the record date, 21,536,069
shares of common stock were issued and outstanding.
|
|
|
|
|
Q:
|
Who will count the votes?
|
|
|
|
|
A:
|
One or
more inspectors of election will tabulate the votes.
|
|
|
|
|
Q:
|
Is my vote confidential?
|
|
|
|
|
A:
|
Proxy
instructions, ballots, and voting tabulations that identify
individual stockholders are handled in a manner that protects your
voting privacy. Your vote will not be disclosed, either within YGYI
or to anyone else, except: (1) as necessary to meet applicable
legal requirements; (2) to allow for the tabulation of votes and
certification of the vote; or (3) to facilitate a successful proxy
solicitation.
|
|
Q:
|
Who will bear the cost of soliciting votes for the 2018 Annual
Meeting?
|
|
|
|
|
A:
|
The
Board of Directors is making this solicitation on behalf of YGYI,
which will pay the entire cost of preparing, assembling, printing,
mailing, and distributing these proxy materials. Certain of our
directors, officers, and employees, without any additional
compensation, may also solicit your vote in person, by telephone,
or by electronic communication. We will not retain the services of
an outside firm to aid in the solicitation of proxies for this
year. Brokerage houses, nominees, fiduciaries and other custodians
will be requested to forward solicitation materials to beneficial
owners and will be reimbursed for their reasonable expenses
incurred in so doing. We may request by telephone, facsimile, mail,
electronic mail or other means of communication the return of the
proxy cards.
|
|
|
|
|
Q:
|
When are stockholder proposals and director nominations due for
next year’s Annual Meeting?
|
|
|
|
|
A:
|
To be
considered for inclusion in next year’s proxy materials, your
proposal must be submitted in writing by February 8, 2019, to the
attention of the Corporate Secretary of Youngevity International,
Inc. at 2400 Boswell Road, Chula Vista, California 91914, and you
must comply with all applicable requirements of Rule 14a-8
promulgated under the Securities Exchange Act of 1934, as amended
(the “Exchange Act”); provided, however, that if our 2019 Annual Meeting of
Stockholders is not held between July 23, 2019 and August 23, 2019,
to be timely, then the deadline is a reasonable amount of time
prior to the date we begin to print and mail our proxy statement
for the 2019 Annual Meeting of Stockholders.
|
PROPOSAL 1
ELECTION OF DIRECTORS
Directors, Executive Officers and Other Key Employees
The
Board of Directors has nominated for annual election as director
each of the individuals identified below, all of whom are incumbent
directors.
THE NOMINEES
|
Name
|
|
Age
|
|
Director Since
|
|
Position
|
|
Stephan Wallach
|
|
51
|
|
2011*
|
|
Chairman and Chief Executive Officer
|
|
David Briskie
|
|
57
|
|
2011
|
|
President, Chief Financial Officer and Director
|
|
Michelle Wallach
|
|
47
|
|
2011*
|
|
Chief Operating Officer and Director
|
|
Richard Renton
|
|
63
|
|
2012
|
|
Director
|
|
William Thompson
|
|
57
|
|
2013
|
|
Director
|
|
Paul Sallwasser
|
|
64
|
|
2017
|
|
Director
|
|
Kevin Allodi
|
|
61
|
|
2017
|
|
Director
|
* Since 1996, Stephen Wallach and Michelle Wallach served as
directors of AL Global Corporation, the private company that merged
with and into Javalution Coffee Company, our predecessor in
2011.
THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE YOUR SHARES FOR THE
ELECTION
OF EACH OF THESE NOMINEES
Currently, our
Board of Directors consists of seven (7) members, all of whom are
being nominated to serve as director: Stephan Wallach, David
Briskie, Michelle Wallach, Richard Renton, William Thompson, Kevin
Allodi and Paul Sallwasser. All of the current member nominees have
been nominated by our Board of Directors that serves as our
Nominating Committee for election as directors of YGYI. The Board
of Directors believes that it is in YGYI’s best interests to
elect the above-described seven (7) nominees, each to serve as a
director until the next Annual Meeting of Stockholders and until
his successor shall have been duly elected and qualified. All of
the nominees have consented to being named in this proxy statement
and to serve as a director if elected. At the time of the 2018
Annual Meeting, if any of the nominees named above is not available
to serve as director (an event that the Board of Directors does not
currently have any reason to anticipate), all proxies may be voted
for any one or more other persons that the Board of Directors
designates in their place. It is the intention of the persons named
as proxies to vote all shares of common stock for which they have
been granted a proxy for the election of each of the nominees, each
to serve as a director until the next annual meeting of
stockholders and until his successor shall have been duly elected
and qualified.
The
Board believes that each of the nominees is highly qualified to
serve as a member of the Board and each has contributed to the mix
of skills, core competencies and qualifications of the Board. When
evaluating candidates for election to the Board, the Board seeks
candidates with certain qualities that it believes are important,
including experience, skills, expertise, personal and professional
integrity, character, business judgment, time availability in light
of other commitments, dedication, conflicts of interest, those
criteria and qualifications described in each director’s
biography below and such other relevant factors that the Board
considers appropriate in the context of the needs of the Board of
Directors.
Director Independence
Our
common stock is listed on Nasdaq Capital Market
(“NASDAQ”). Inasmuch as we qualify as a
“controlled company” because Mr. and Mrs. Wallach hold
in excess of 50% of our voting securities, we qualify for certain
exemptions to the NASDAQ listing requirements, including the
requirement that a majority of our directors be independent, and
the requirements to have a compensation committee and a nominating
committee, each comprised of entirely independent directors. Our
Board of Directors has determined that William Thompson, Kevin
Allodi and Paul Sallwasser are independent directors.
INFORMATION ABOUT THE NOMINEES
Set
forth below are summaries of the background, business experience
and descriptions of the principal occupation for at least the past
five years of each of our current nominees for election as
directors:
Stephan Wallach, Chief Executive Officer and
Chairman of the Board
Mr.
Stephan Wallach was appointed to the position of Chief Executive
Officer on July 11, 2011 pursuant to the terms of the merger
agreement between Youngevity® and Javalution. He previously
served as President and Chief Executive Officer of AL Global
Corporation. He has served as a director of our Company since
inception and was appointed Chairman of the Board on January 9,
2012. In 1996, Mr. Wallach and the Wallach family together launched
our Youngevity® division and served as its co-founder and
Chief Executive Officer from inception until the merger with
Javalution. Mr. Wallach’s extensive knowledge about our
business operations and our products makes him an exceptional board
member.
David Briskie, President, Chief Financial
Officer and Director
Mr.
David Briskie was appointed to the position of President on October
30, 2015 and Chief Financial Officer on May 15, 2012. Prior to
that, Mr. Briskie served as President of Commercial Development, a
position he was appointed to on July 11, 2011 pursuant to the terms
of the merger agreement between Youngevity® and Javalution.
From February 2007 until the merger he served as the Chief
Executive Officer and director of Javalution and since September
2007 has served as the Managing Director of CLR Roasters. Prior to
joining Javalution in 2007, Mr. Briskie had an 18-year career with
Drew Pearson Marketing (“DPM”), a consumer product
company marketing headwear and fashion accessories. He began his
career at DPM in 1989 as Executive Vice President of Finance and
held numerous positions in the company, including vice president of
marketing, chief financial officer, chief operating officer and
president. Mr. Briskie graduated magna cum laude from Fordham
University with a major in marketing and finance. Mr.
Briskie’s experience in financial matters, his overall
business understanding, as well as his familiarity and knowledge
regarding public companies make him an exceptional board
member.
Michelle Wallach, Chief Operating Officer and
Director
Ms.
Michelle Wallach was appointed to the position of Chief Operating
Officer on July 11, 2011 pursuant to the terms of the merger
agreement between Youngevity® and Javalution. She previously
served as Corporate Secretary and Manager of AL Global Corporation.
She has a background in network marketing, including more than 20
years in distributor management. Her career in network marketing
began in 1991 in Portland, Oregon, where she developed a
nutritional health product distributorship. In 1996, Ms. Wallach
and the Wallach family together launched our Youngevity®
division and served as its co-founder and Chief Operations Officer
from inception until the merger with Javalution. Ms. Wallach has an
active role in promotion, convention and event planning, domestic
and international training, and product development. Ms.
Wallach’s prior experience with network marketing and her
extensive knowledge about our business operations and our products
make her an exceptional board member.
Richard Renton, Director
Mr.
Richard Renton was appointed to our Board of Directors on January
9, 2012, and currently serves on the Youngevity Science and
Athletic Advisory Boards. For the past 22 years, Mr. Renton owned
his own business providing nutritional products to companies like
ours. We purchase certain products from Mr. Renton’s company
WVNP, Inc. Mr. Renton attended University of Oregon and Portland
State University, earning degrees in Sports Medicine, Health,
Physical Education, and Chemistry. He has served as an Associate
Professor at PSU in Health and First Aid, and was the Assistant
Athletic Trainer for PSU, the Portland Timbers Soccer Team, and the
Portland Storm Football team. Mr. Renton is a board certified
Athletic Trainer with the National Athletic Trainers Association.
Mr. Renton’s understanding of nutritional products makes him
an exceptional board member.
William Thompson, Director
Mr.
William Thompson was appointed to our Board of Directors on June
10, 2013 and currently serves as the Chief Financial Officer of
Broadcast Company of the Americas, which operates three radio
stations in San Diego, California. He served as Corporate
Controller for the Company from 2011 to March 2013 and for Breach
Security, a developer of web application firewalls, from 2007 to
2010. Prior to 2007, Mr. Thompson was Divisional Controller for
Mediaspan Group and Chief Financial Officer of Triathlon
Broadcasting Company. Mr. Thompson’s achievements in
financial matters and his overall business understanding make him
an exceptional board member.
Paul Sallwasser, Director
Mr. Paul Sallwasser was appointed to our Board of Directors on June
5, 2017. Mr. Sallwasser is a certified public accountant, joined
the audit staff of Ernst & Young LLP in 1976 and remained with
Ernst & Young LLP for 38 years. Mr. Sallwasser has served a
broad range of clients primarily in the healthcare and
biotechnology industries of which a significant number were SEC
registrants. He became a partner of Ernst & Young in 1988. From
2011 until he retired from Ernst & Young LLP, Mr. Sallwasser
served in the national office as a member of the Quality and
Regulatory Matters Group working with regulators and the Public
Company Accounting Oversight Board (PCAOB). Mr. Sallwasser’s
qualification as an “audit committee financial expert,”
as defined by the rules of the SEC, and his vast audit experience
serves as the basis for his position on the Board and its Audit
Committee.
Kevin Allodi, Director
Mr. Kevin Allodi was appointed to our Board of Directors on June 5,
2017. Mr. Allodi is currently the CEO and Co-Founder of Philo
Broadcasting, a media holding company that includes award-winning
digital content studio Philo Media and a broadcast television
production company Backyard Productions. Philo is headquartered in
Chicago with production offices in Los Angeles. Prior to joining
Portal (described above) Mr. Allodi spent ten years with
Communications Industry Division of Computer Sciences Corporation
(NYSE:CSC) where he was VP Global Billing & Customer Care
practice. Currently, Mr. Allodi also serves as a Managing Partner
of KBA Holdings, LLC, a private equity investment firm active in
the digital media, hi-tech, alternative energy and bio-tech
industries. Mr. Allodi serves as a partner, limited partner,
director and/or advisory board member to several portfolio
companies including G2T3V LLC, uBid, Ridge Partners LLC, IMI
Innovations, Inc. and is on the Board of Directors of FNBC Bank
& Trust. Mr. Allodi’s business experience and investment
experience serves as the basis for his position on the Board and
its Audit Committee.
Family Relationships
Other
than Stephan Wallach and Michelle Wallach, who are husband and
wife, none of our officers or directors has a family relationship
with any other officer or director.
Vote Required
Provided that a
quorum is present, the nominees for director receiving a plurality
of the votes cast at the 2018 Annual Meeting in person or by proxy
will be elected.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE
ELECTION
OF THESE NOMINEES AS DIRECTORS
Board Leadership Structure
We
currently have the same person serving as our Chairman of the Board
and Chief Executive Officer and we do not have a formal policy on
whether the same person should (or should not) serve as both the
Chief Executive Officer and Chairman of the Board. Mr. Briskie
currently serves as our President and Chief Financial Officer. Due
to the size of our company, we believe that this structure is
appropriate. Mr. Wallach has served as the Chairman of the Board
and Chief Executive Officer since AL Global Corporation, the
private company that he owned, merged into our predecessor in 2011
and he served as the Chairman of the Board and Chief Executive
Officer of Youngevity International, Inc., since inception. In
serving as Chairman of the Board, Mr. Wallach serves as a
significant resource for other members of management and the Board
of Directors.
We do
not have a separate lead director. We believe the combination of
Mr. Wallach as our Chairman of the Board and Chief Executive
Officer and Mr. Briskie as our President and Chief Financial
Officer has been an effective structure for our company. Our
current structure is operating effectively to foster productive,
timely and efficient communication among the independent directors
and management. We do have active participation in our committees
by our independent directors. Each committee performs an active
role in overseeing our management and there are complete and open
lines of communication with the management and independent
directors.
Oversight of Risk Management
The
Board of Directors has an active role, as a whole and also at the
committee level, in overseeing management of our risks. The Board
of Directors regularly reviews information regarding our strategy,
finances and operations, as well as the risks associated with
each.
Overview
Corporate Governance Guidelines
We are
committed to maintaining the highest standards of business conduct
and corporate governance, which we believe are fundamental to the
overall success of our business, serving our stockholders well and
maintaining our integrity in the marketplace. Our Corporate
Governance Guidelines and Code of Business Conduct and Ethics,
together with our Certificate of Incorporation, Bylaws and the
charters of our Board Committees, form the basis for our corporate
governance framework. As discussed above, our Board of Directors
has established three standing committees to assist it in
fulfilling its responsibilities to us and our stockholders: the
Audit Committee, the Compensation Committee and the Investment
Committee. The Board of Directors performs the functions typically
assigned to a Nominating and Corporate Governance
Committee.
Our
Corporate Governance Guidelines are designed to ensure effective
corporate governance of our company. Our Corporate Governance
Guidelines cover topics including, but not limited to, director
qualification criteria, director responsibilities, director
compensation, director orientation and continuing education,
communications from stockholders to the Board, succession planning
and the annual evaluations of the Board and its Committees. Our
Corporate Governance Guidelines are reviewed regularly by the Board
and revised when appropriate.
Code of Business Conduct and Ethics
We have
adopted a Code of Business Conduct and Ethics that applies to all
of our employees, officers and directors. This Code constitutes a
“code of ethics” as defined by the rules of the SEC.
Copies of the code may be obtained free of charge from our website,
www.ygyi.com. Any
amendments to, or waivers from, a provision of our code of ethics
that applies to any of our executive officers will be posted on our
website in accordance with the rules of the SEC.
INFORMATION REGARDING THE COMMITTEES OF THE BOARD OF
DIRECTORS
Committees of the Board of Directors
|
Board Members
|
|
Audit
Committee
|
|
|
Compensation
Committee
|
|
|
Investment
Committee
|
|
|
Stephan
Wallach
|
|
-
|
|
|
Chairman
|
|
|
Member
|
|
|
David
Briskie
|
|
-
|
|
|
Member
|
|
|
Chairman
|
|
|
Michelle
Wallach
|
|
-
|
|
|
-
|
|
|
-
|
|
|
Richard
Renton
|
|
-
|
|
|
-
|
|
|
-
|
|
|
William
Thompson
|
|
Chairman
|
|
|
-
|
|
|
-
|
|
|
Paul
Sallwasser
|
|
Member
|
|
|
-
|
|
|
-
|
|
|
Kevin
Allodi
|
|
Member
|
|
|
-
|
|
|
-
|
|
Director Independence
Our
Board of Directors has determined that William Thompson, Paul
Sallwasser and Kevin Allodi are each independent directors in
accordance with the definition of independence applied by the
NASDAQ Stock Market. Since we qualify as a “controlled
company” we qualify for certain exemptions to the NASDAQ
Capital Market listing requirements.
Board Committees
Audit Committee. The Audit Committee of
the Board of Directors currently consists of William Thompson
(Chair), Paul Sallwasser and Kevin Allodi. The functions of the
Audit Committee include the retention of our independent registered
public accounting firm, reviewing and approving the planned scope,
proposed fee arrangements and results of the Company’s annual
audit, reviewing the adequacy of the Company’s accounting and
financial controls and reviewing the independence of the
Company’s independent registered public accounting firm. The
Board has determined that William Thompson, Paul Sallwasser and
Kevin Allodi are each an “independent director” under
the listing standards of The NASDAQ Stock Market. The Board of
Directors has also determined that each of Mr. Thompson and Mr.
Sallwasser is an “audit committee financial expert”
within the applicable definition of the SEC. The Audit Committee is
governed by a written charter approved by the Board of Directors, a
copy of which is available on our website at www.ygyi.com. Information contained on
our website are not incorporated by reference into and do not form
any part of this proxy statement. We have included the website
address as a factual reference and do not intend it to be an active
link to the website.
Compensation Committee. The
Compensation Committee of the Board of Directors currently consists
of Stephan Wallach (Chair) and David Briskie. As a controlled
company we are exempt from the NASDAQ independence requirements for
the Compensation Committee. The functions of the Compensation
Committee include the approval of the compensation offered to our
executive officers and recommending to the full Board of Directors
the compensation to be offered to our directors, including our
Chairman. None of the members of the Compensation Committee are
independent under the listing standards of The NASDAQ Stock Market.
In addition, the members of the Compensation Committee do not
qualify as “non-employee directors” for purposes of
Rule 16b-3 under the Exchange Act or as “outside
directors” for purposes of Section 162(m) of the Internal
Revenue Code of 1986, as amended. The Compensation Committee is
governed by a written charter approved by the Board of Directors, a
copy of which is available on our website at www.ygyi.com. Information contained on
our website are not incorporated by reference into and do not form
any part of this proxy statement. We have included the website
address as a factual reference and do not intend it to be an active
link to the website.
Investment Committee. The Investment
Committee of the Board of Directors currently consists of David
Briskie (Chair) and Stephan Wallach as a member. This Committee
determines, approves, and reports to the Board of Directors on all
elements of acquisitions and investments for the
Company.
We do
not currently have a separate nominating committee and instead our
full board of directors performs the functions of a nominating
committee. Due to our size we believe that this is an appropriate
structure. As a controlled company we are exempt from the NASDAQ
requirements for a nominating committee.
BOARD AND COMMITTEE MEETINGS
During
our fiscal year ended December 31, 2017, our Board of Directors
held 1 meeting and our audit committee held 2 meetings. Each of our
incumbent directors that were directors during our fiscal year
ended December 31, 2017 attended no less than 75% of the meetings
of the Board of Directors and Board committees on which such
director served during 2017.
DIRECTOR ATTENDANCE AT ANNUAL MEETINGS
Our
directors are encouraged, but not required, to attend the Annual
Meeting of Stockholders.
2017 DIRECTOR COMPENSATION
The
following table sets forth information for the fiscal year ended
December 31, 2017 regarding the compensation of our directors who
at December 31, 2017 were not also named executive
officers.
|
Name
|
Fees
Earned or
Paid
in Cash ($)
|
|
|
|
|
Richard
Renton
|
-
|
20,437
|
-
|
20,437
|
|
William
Thompson
|
-
|
20,437
|
-
|
20,437
|
|
Paul
Sallwasser
|
-
|
14,708
|
-
|
14,708
|
|
Kevin
Allodi
|
-
|
14,708
|
-
|
14,708
|
|
(1)
|
The
amounts in the “Option Awards” column reflect the
dollar amounts recognized as compensation expense for the financial
statement reporting purposes for stock options for the fiscal year
ended December 31, 2017 in accordance with FASB ASC Topic 718. The
fair value of the options was determined using the Black-Scholes
model.
|
As of
December 31, 2017, the following table sets forth the number of
aggregate outstanding option awards held by each of our directors
who were not also named executive officers:
|
Name
|
Aggregate
Number
of
Option
Awards
|
|
Richard
Renton
|
15,000
|
|
William
Thompson
|
17,500
|
|
Paul
Sallwasser
|
5,000
|
|
Kevin
Allodi
|
5,000
|
We
grant to non-employee members of the Board of Directors upon
appointment, stock options to purchase shares of our common stock
at an exercise price equal to the fair market value of the common
stock on the date of grant, and additional stock options each year
thereafter for their service. We also reimburse the non-employee
directors for travel and other out-of-pocket expenses incurred in
attending board of director and committee meetings. During 2017, we
granted each non-employee director a ten-year option to purchase
5,000 shares of our common stock at an exercise price of $4.53, all
of which vested immediately. For the year ending December 31, 2018,
we intend to grant each non-employee director an option to acquire
shares of common stock having a fair market value of $50,000 on the
grant date.
Equity Compensation Plan Information
The
2012 Stock Option Plan, or the Plan, is our only active equity
incentive plan pursuant to which options to acquire common stock
have been granted and are currently outstanding.
As of
December 31, 2017, the number of stock options and restricted
common stock outstanding under our equity compensation plans, the
weighted average exercise price of outstanding options and
restricted common stock and the number of securities remaining
available for issuance were as follows:
|
Plan
category
|
Number
of
securities
issued
under
equity
compensation
plan
|
Weighted-average
exercise
price of
outstanding
options
|
Number
of securities remaining available for
future
issuance under equity compensation plans
|
|
Equity compensation
plans approved by security holders
|
-
|
$-
|
-
|
|
Equity compensation
plans not approved by security holders
|
2,084,923
|
4.70
|
1,885,789
|
|
Total
|
2,084,923
|
$4.70
|
1,885,789
|
On
February 23, 2017, our Board of Directors received the approval of
our stockholders, to amend the 2012 Stock Option Plan (the
“Plan”) to increase the number of shares of common
stock available for grant and to expand the types of awards
available for grant under the Plan. The amendment of the Plan
increased the number of shares of our common stock that may be
delivered pursuant to awards granted during the life of the Plan
from 2,000,000 to 4,000,000 shares authorized (as adjusted for the
1-for-20 reverse stock split, which was effective on June 7, 2017).
The Plan as amended allows for the grant of: (i) incentive stock
options; (ii) nonqualified stock options; (iii) stock appreciation
rights; (iv) restricted stock; and (v) other stock-based and
cash-based awards to eligible individuals. The terms of the awards
will be set forth in an award agreement, consistent with the terms
of the Plan. No stock option is exercisable later than ten years
after the date it is granted.
Section 16(a) Beneficial Ownership Reporting
Compliance
Section
16 of the Exchange Act and the related rules of the SEC require our
directors and executive officers and beneficial owners of more than
10% of our common stock to file reports, within specified time
periods, indicating their holdings of and transactions in our
common stock and derivative securities. Based solely on a review of
such reports provided to us and written representations from such
persons regarding the necessity to file such reports, we are not
aware of any failures to file reports or report transactions in a
timely manner during our fiscal year ended December 31, 2017 other
than late filings of a Form 3 for Mr. Allodi, a Form 4 to report
stock option issuances for Mr. Briskie, Mr. Renton and Mr. Thompson
and a Form 4 to report the issuances of securities in connection
with our 2017 private placement to Mr. Sallwasser upon exchange of
securities issued to Mr. Sallwasser in our 2015 private
placement.
Board Composition
Our
Board regularly assesses the appropriate size of our Board, and
whether any vacancies on our Board are expected due to retirement
or otherwise. In the event that vacancies are anticipated, or
otherwise arise, the Board will consider various potential
candidates who may come to the attention of the Board through
current Board members, professional search firms, stockholders or
other persons. Each candidate brought to the attention of the
Board, regardless of who recommended such candidate, is considered
on the basis of the criteria set forth in our corporate governance
guidelines. As stated above, our Board will consider candidates
proposed for nomination by our significant stockholders.
Stockholders may propose candidates by submitting the names and
supporting information to: Board of Directors in care of the
Corporate Secretary, Youngevity International, Inc. 2400 Boswell,
Chula Vista, California 91914. Supporting information should
include (a) the name and address of the candidate and the proposing
stockholder, (b) a comprehensive biography of the candidate and an
explanation of why the candidate is qualified to serve as a
director taking into account the criteria identified in our
corporate governance guidelines, (c) proof of ownership, the class
and number of shares, and the length of time that the shares of our
voting securities have been beneficially owned by each of the
candidate and the proposing stockholder, and (d) a letter signed by
the candidate stating his or her willingness to serve, if
elected.
PROPOSAL 2
RATIFICATION OF APPOINTMENT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The
Audit Committee of the Board of Directors has selected Mayer
Hoffman McCann P.C., an independent registered public accounting
firm, to audit our books and financial records for the year ending
December 31, 2018. We are asking our stockholders to ratify the
appointment of Mayer Hoffman McCann P.C. as our independent
registered public accounting firm for fiscal 2018.
A
representative of Mayer Hoffman McCann P.C. is expected to be
present either in person or via teleconference at the 2018 Annual
Meeting and available to respond to appropriate questions, and will
have the opportunity to make a statement if he or she desires to do
so.
Vote Required
The
affirmative vote of a majority of the issued and outstanding shares
entitled to vote and represented at the 2018 Annual Meeting in
person or by proxy will be required to approve the ratification of
the appointment of Mayer Hoffman McCann P.C. as our independent
registered public accounting firm for fiscal 2018. Abstentions will
be counted and will have the same effect as a vote against the
proposal. Ratification of the appointment of Mayer Hoffman McCann
P.C. by our stockholders is not required by law, our bylaws or
other governing documents. As a matter of policy, however, the
appointment is being submitted to our stockholders for ratification
at the 2018 Annual Meeting. If our stockholders fail to ratify the
appointment, the Audit Committee will reconsider whether or not to
retain that firm. Even if the appointment is ratified, the Audit
Committee, in its discretion, may direct the appointment of
different independent auditors at any time during the year if they
determine that such a change would be in our best interest and the
best interests of our stockholders.
OUR BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT YOU VOTE FOR
RATIFICATION OF THE SELECTION OF MAYER HOFFMAN MCCANN P.C. AS OUR
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR
ENDING ON DECEMBER 31, 2018.
AUDIT COMMITTEE REPORT 1
The
Audit Committee has reviewed and discussed our audited consolidated
financial statements as of and for the year ended December 31, 2017
with our management and Mayer Hoffman McCann P.C., our independent
registered public accounting firm. Further, the Audit Committee has
discussed with Mayer Hoffman McCann P.C. the matters required to be
discussed under auditing standards generally accepted in the United
States, including those matters set forth in the Public Company
Accounting Oversight Board (“PCAOB”) Auditing Standard
No. 1301, Communications with
Audit Committees, as amended and as adopted by the Public
Company Accounting oversight Board in Rule 3200T, other standards
of the Public Company Accounting Oversight Board (United States),
rules of the SEC, and other applicable regulations, relating to the
firm’s judgment about the quality, not just the
acceptability, of our accounting principles, the reasonableness of
significant judgments and estimates, and the clarity of disclosures
in the consolidated financial statements.
The
Audit Committee also has received the written disclosures and the
letter from Mayer Hoffman McCann P.C. required by PCAOB Ethics and
Independence Rule 3526, Communication with Audit Committees Concerning
Independence, which relate to Mayer Hoffman McCann
P.C.’s independence from YGYI, and has discussed with Mayer
Hoffman McCann P.C. regarding its independence from YGYI. The Audit
Committee has also considered whether the independent registered
public accounting firm’s provision of non-audit services to
YGYI is compatible with maintaining the firm’s independence.
The Audit Committee has concluded that the independent registered
public accounting firm is independent from YGYI and its management.
The members of the Audit Committee are not our employees and are
not performing the functions of auditors or accountants.
Accordingly, it is not the duty or responsibility of the Audit
Committee or its members to conduct “field work” or
other types of auditing or accounting reviews or procedures or to
set auditor independence standards. Members of the Audit Committee
necessarily rely on the information provided to them by management
and the independent auditors. Accordingly, the Audit
Committee’s considerations and discussions referred to above
do not constitute assurance that the audit of our consolidated
financial statements has been carried out in accordance with
generally accepted accounting principles or that our auditors are
in fact independent.
Based
on the reviews, reports and discussions referred to above, the
Audit Committee recommended to the Board of Directors, and the
Board approved, that our audited consolidated financial statements
for the year ended December 31, 2017 and management’s
assessment of the effectiveness of our internal control over
financial reporting be included in our Annual Report on Form 10-K
for the year ended December 31, 2017, for filing with the SEC. The
Audit Committee has recommended, and the Board of Directors has
approved, subject to stockholder ratification, the selection of
Mayer Hoffman McCann P.C. as our independent registered public
accounting firm for the year ending December 31, 2018.
Submitted by the
Audit Committee of Our Board of Directors.
|
|
Members
of the Audit Committee:
|
|
|
|
|
|
|
|
|
William
Thompson
|
|
|
Kevin
Allodi
Paul
Sallwasser
|
———————
1
The material in
this report is not “soliciting material,” is not deemed
“filed” with the SEC and is not incorporated by
reference in any filing of YGYI under the Securities Act of 1933,
as amended, or the Exchange Act, whether made before or after the
date hereof and irrespective of any general incorporation language
in any such filing.
Independent Registered Public Accounting Firm’s Fee
Summary
The
following table provides information regarding the fees billed to
us by Mayer Hoffman McCann P.C. for the years ended December 31,
2017 and 2016. Mayer Hoffman McCann P.C. leases substantially all
of its personnel, who work under the control of Mayer Hoffman
McCann P.C. shareholders, from wholly-owned subsidiaries of CBIZ,
Inc., including CBIZ MHM, LLC, in an alternative practice
structure. All fees described below were approved by the Board or
the Audit Committee:
|
|
|
|
|
Audit Fees and Expenses (1)
|
$523,000
|
$323,000
|
|
Audit Related Fees (2)
|
-
|
13,000
|
|
|
$523,000
|
$336,000
|
|
(1)
|
Audit
fees and expenses were for professional services rendered for the
audit and reviews of the consolidated financial statements of the
Company, professional services rendered for issuance of consents
and assistance with review of documents filed with the
SEC.
|
|
(2)
|
The
audit related fees were for professional services rendered
for assurance
and related services by the principal accountant that are
reasonably related to the performance of the audit or review of the
Company’s financial statements and are not reported under
audit fees.
|
Pre-Approval Policies and Procedures
Consistent
with SEC policies regarding auditor independence, the Audit
Committee has responsibility for appointing, setting compensation
and overseeing the work of the independent registered public
accounting firm. In recognition of this responsibility, the Audit
Committee has established a policy to pre-approve all audit and
permissible non-audit services provided by the independent
registered public accounting firm.
Prior
to the engagement of the independent registered public accounting
firm for the next year’s audit, management will submit a list
of services and related fees expected to be rendered during that
year for audit services, audit-related services, tax services and
other fees to the Audit Committee for approval.
OTHER MATTERS
The
Board knows of no other business that will be presented to the
Annual Meeting. If any other business is properly brought before
the Annual Meeting, proxies will be voted in accordance with the
judgment of the persons named therein.
EXECUTIVE COMPENSATION
NARRATIVE DISCLOSURE TO SUMMARY COMPENSATION TABLE
Overview
of Our Compensation Program
A. Philosophy and
Objectives
Our primary
objective with respect to executive compensation is to design
compensation programs that will align executives’
compensation with our overall business strategies for the creation
of stockholder value and attract, motivate and retain highly
qualified executives, drive high performance by connecting
compensation to our financial operating, and strategic goals and
results and appropriately reward high performance. To accomplish
this objective, executive compensation is reviewed annually to
ensure that compensation levels are competitive and reasonable
given our level of performance and other comparable companies with
which we compete for talent. Our executive compensation program is
designed to appropriately reward both individual and collective
performance that meets and exceeds our annual, long-term and
strategic goals. To accomplish this objective, a substantial
percentage of total compensation is variable, “at
risk”, both through cash bonus compensation and equity
compensation.
YGYI
seeks to achieve these objectives through four key compensation
elements:
The
Compensation Committee uses a simple and straightforward approach
in compensating our Named Executive Officers (“NEO”) in
which base salary, annual incentives and stock options are the
principal components. In addition, executives generally participate
in the same benefit programs as other full-time
employees.
In
order to enhance the Compensation Committee’s ability to
carry out its responsibilities effectively, as well as maintain
strong links between executive pay and performance, the
Compensation Committee reviews compensation information for each
NEO which includes the following information:
●
the annual
compensation and benefit values that are being offered to each
executive;
●
the value of all
outstanding equity awards; and
●
the Compensation
Committee also meets with our senior management in connection with
compensation matters, and may retain and meet in executive session
with, compensation and other advisors from time to
time.
B. Compensation Administration
Roles and Responsibilities of Compensation Committee
The primary purpose
of the Compensation Committee is to conduct reviews of our general
executive compensation policies and strategies and oversee and
evaluate our overall compensation structure and programs. The
Compensation Committee seeks to confirm that total compensation
paid to the Chief Executive Officer, Chief Financial Officer and
Chief Operating Officer is reasonable and competitive. All of these
responsibilities of the Compensation Committee include, but are not
limited to:
●
Establishing on an
annual basis performance goals and objectives for purposes of
determining the compensation of our Chief Executive Officer and
other senior executive officers, evaluating the performance of such
officers in light of those goals and objectives, and setting the
compensation level for those officers based on this
evaluation.
●
Recommending to the
Board the compensation for Board members (including retainer,
committee and committee chair’s fees, stock options and other
similar items as appropriate).
●
Reviewing the
competitive position of, and making recommendations to the Board
with respect to, the cash-based and equity-based compensation plans
and other programs of YGYI relating to compensation and
benefits.
●
Reviewing the
financial performance and the operations of our major benefit
plans.
●
Overseeing the
administration of our stock option and other executive compensation
plans, including recommending to the Board of Directors the
granting of options and awards under the plans, and the approval or
disapproval of the participation of individual employees in those
plans.
●
Reviewing and
approving for our Chief Executive Officer and other senior
executive officers material perquisites or other in-kind
benefits.
Additional
information regarding the Compensation Committee’s
responsibilities is set forth in its charter, which is posted on
our website at www.YGYI.com.
C. Competitive Considerations and Components of
Compensation
In
making compensation decisions with respect to each element of
compensation, the Compensation Committee considers the competitive
market for executives and compensation levels provided by
comparable companies. The Compensation Committee regularly reviews
the compensation practices at companies with which it competes for
talent, such as businesses engaged in activities similar to those
of YGYI, including other similarly sized companies in the direct
selling business.
The
Compensation Committee generally targets total executive
compensation at the median of compensation packages for
Code Section 162(m) Provisions executives in similar
positions and with similar responsibilities and experience at
similar companies of comparable size with the opportunity for top
quartile compensation based upon individual and company
performance. The Compensation Committee’s choice of this
target percentile reflects our consideration for our
stockholders’ interests in paying what is competitive, but
not more than that which is competitive, to achieve our corporate
goals, while conserving cash and equity as much as
practicable.
We provide our
NEO's a base salary commensurate with their position,
responsibilities and experience. In setting the base salary, the
Compensation Committee considers the scope and accountability
associated with each NEO’s position and such factors as
performance and experience of each NEO. We design base pay to
provide the essential reward for an employee’s work, and are
required to be competitive in attracting talent. Once base pay
levels are initially determined, increases in base pay may be
provided to recognize an employee’s specific performance
achievements. The base salaries are targeted to be competitive with
other similar companies. In an effort to preserve cash, we did not
provide cash bonuses in 2017. However, in 2017 long term equity
incentive awards were an important component of the compensation of
our President who also serves as our Chief Financial Officer and as
such in 2017, we issued our President/Chief Financial Officer
250,000 restricted stock units vesting over a six year period.
Inasmuch as our Chief Executive Officer and Chief Operating Officer
hold a significant stock ownership position in YGYI, we did not
issue to them any equity incentive awards. We believe the Chief
Executive Officer and Chief Operating Officer’s ownership
position in YGYI, together with the long-term equity incentive
awards to our President/Chief Financial Officer, motivates their
achievement of our financial and strategic objectives and aligns
their interests with those of our
stockholders.
Role of the Chief Executive Officer and Chief Financial
Officer
Our Chief Executive
Officer, Mr. Stephen Wallach, and our President/Chief Financial
Officer, Mr. David Briskie each makes recommendations to the
Compensation Committee regarding the compensation of our other
NEO's. Neither participates in any discussions or processes
concerning his own compensation.
COMPENSATION OF EXECUTIVE OFFICERS
Summary Compensation Table
The
following table sets forth all compensation awarded, earned or paid
in cash and non-cash compensation for services rendered by our
principal executive officer, principal financial officer and each
executive officer whose compensation exceeded $100,000 during each
of the fiscal years ended December 31, 2017 and 2016 by our
“named executive officers,” consisting of each
individual serving as (i) principal Chief Executive Officer, (ii)
our principal Chief Financial Officer, and (iii) Chief Operating
Officer.
|
|
Year
|
|
Salary
($)
|
|
|
Bonus
($)
|
|
|
Option
Awards (2)
($)
|
|
|
Total
($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stephan Wallach (1)
|
2017
|
|
|
357,212
|
|
|
|
-
|
|
|
|
-
|
|
|
|
357,212
|
|
|
Chief Executive Officer
|
2016
|
|
|
282,500
|
|
|
|
179,730
|
|
|
|
-
|
|
|
|
462,230
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
David Briskie (1)(2)
|
2017
|
|
|
357,212
|
|
|
|
-
|
|
|
|
670,875
|
|
|
|
1,028,087
|
|
|
President and Chief Financial Officer
|
2016
|
|
|
282,500
|
|
|
|
179,730
|
|
|
|
748,500
|
|
|
|
1,210,730
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Michelle Wallach (1)
|
2017
|
|
|
192,660
|
|
|
|
-
|
|
|
|
-
|
|
|
|
192,660
|
|
|
Chief Operating Officer
|
2016
|
|
|
192,660
|
|
|
|
179,730
|
|
|
|
-
|
|
|
|
372,390
|
|
|
(1)
|
Mr. Stephan Wallach, Mr. David Briskie, and Ms. Michelle Wallach
have direct and or indirect (beneficially) distributor positions in
our company that pay income based on the performance of those
distributor positions in addition to their base salaries, and the
people and or companies supporting those positions based upon the
contractual agreements that each and every distributor enter into
upon engaging in the network marketing business. The contractual
terms of these positions are the same as those of all the other
individuals that become distributors in our Company. There are no
special circumstances for these officers/directors. Mr. Stephan
Wallach and Ms. Michelle Wallach received or beneficially received
an aggregate of $362,292 and $357,002 in 2017 and 2016,
respectively related to their distributor positions, which are not
included above. Mr. Briskie beneficially received $19,196 and
$23,889 in 2017 and 2016, respectively, related to his
spouse’s distributor position, which is not included
above.
|
|
(2)
|
We use a Black-Scholes option-pricing model (Black-Scholes model)
to estimate the fair value of the stock option grant. Expected
volatility is calculated based on the historical volatility of our
stock. The risk-free interest rate is based on the U.S. Treasury
yield for a term equal to the expected life of the options at the
time of grant. The amounts do not represent the actual amounts paid
to or released by any of the Named Executive Officers during the
respective periods.
|
Outstanding Equity Awards at Fiscal Year-End
The
table below reflects all outstanding equity awards made to each of
the named executive officers that are outstanding as of December
31, 2017. We currently grant stock-based awards pursuant to our
2012 Stock Option Plan.
|
|
|
|
|
|
|
|
No. Of
Securities
Underlying
Unexercised
Options (#)
Exercisable
|
No. Of
Securities
Underlying
Unexercised
Options (#)
Unexercisable
|
Option
Exercise
Price
($)
|
|
No.
Of Shares
or Units
of Stock
That Have Not
Vested (#)
|
|
|
Market Value
Of Shares or
Units of
Stock That
Have Not
Vested ($)
|
|
|
Stephan
Wallach
|
125,000(1)
|
-
|
$4.40
|
5/31/2022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
David
Briskie
|
250,000(2)
|
-
|
$4.40
|
5/31/2022
|
|
|
|
|
|
|
|
40,000(3)
|
10,000
|
$3.60
|
10/31/2023
|
|
|
|
|
|
|
|
60,000(4)
|
40,000
|
$3.80
|
10/30/2024
|
250,000(6)
|
|
$
|
1,032,500
|
|
|
|
50,000(5)
|
200,000
|
$5.40
|
12/27/2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Michelle
Wallach
|
125,000(7)
|
-
|
$4.40
|
5/31/2022
|
|
|
|
|
|
|
(1)
|
125,000
stock options granted on May 31, 2012, vested and
exercisable.
|
|
(2)
|
250,000
stock options granted on May 31, 2012, vested and
exercisable.
|
|
(3)
|
50,000
stock options granted on October 31, 2013, 40,000 stock options
vested and are exercisable, with the remaining option shares
vesting on October 31, 2018.
|
|
(4)
|
100,000
stock options granted on October 30, 2014, 60,000 stock options
vested and are exercisable, with the remaining option shares
vesting in equal annual amounts over the next two years as of
December 31, 2017.
|
|
(5)
|
250,000
stock options granted on December 27, 2016, 50,000 stock options
vested and are exercisable, with the remaining option shares
vesting in equal annual amounts over the next four years as of
December 31, 2017.
|
|
(6)
|
250,000
restricted stock units were granted on August 9, 2017, each unit
representing contingent right to receive one share of common stock,
vesting as follows: (i) Year 3 - 25,000 shares; (ii) Year 4 –
37,500 shares; (iii) Year 5 - 125,000 shares; and (iv) Year 6
– 62,500 shares; if Mr. Briskie continues to serve as an
executive officer or otherwise is not terminated for cause prior to
such dates. The market value of the restricted stock units was
multiplied by the closing market price of our common stock at the
end of the 2017 fiscal year, which was $4.13 on December 29, 2017
(the last business day of the 2017 fiscal year.)
|
|
(7)
|
125,000
stock options granted on May 31, 2012, vested and
exercisable.
|
Employment Agreements
Our
executive officers work as at-will employees. We do not have any
written employment agreements with any of our executive
officers.
Code Section 162(m) Provisions
Prior
to the enactment of the Tax Cut and Jobs Act of 2017 (the
“Tax Act”), Section 162(m) of the Internal Revenue
Code precluded a public corporation from taking a tax deduction for
certain compensation in excess of $1.0 million in any one year
paid to its Chief Executive Officer or any of its three other
highest-paid executive officers (not including our Chief Financial
Officer), unless certain specific and detailed criteria are
satisfied. However, certain qualifying
“performance-based” compensation (that is, compensation
paid under a plan administered by a committee of outside directors,
based on achieving objective performance goals, the material terms
of which were approved by shareholders, such as our prior plans)
was not subject to the $1.0 million deduction limit. With the
passage of the Tax Act, only qualifying performance-based
compensation paid pursuant to a binding written contract in effect
on November 2, 2017 (and not modified in any material respect
on or after November 2, 2017) as set forth under the Tax
Act will be eligible for the deduction exception. The Tax
Act also expanded the executive officers covered by
Section 162(m) to include the chief financial officer position
as well as any person who ever was a covered executive for any
prior taxable year, beginning after December 31, 2016. As a
result of these changes, starting in 2018, most compensation
payable to any person who was a named executive officer of the
Company since fiscal year 2016 will not be deductible, regardless
of whether the compensation is performance-based.
OTHER INFORMATION REGARDING THE COMPANY
Security Ownership of Certain Beneficial Owners and
Management
The
following table sets forth certain information regarding the
beneficial ownership of our common stock and options and warrants
to purchase shares of our common stock as of May 30, 2018, by: (i)
each person (or group of affiliated persons) who is known by us to
own more than five percent of the outstanding shares of our common
stock (ii) each of our current directors, (iii) each of our named
executive officers, and (iv) all such directors and executive
officers as a group.
Beneficial
ownership is determined in accordance with SEC rules and generally
includes voting or investment power with respect to securities.
Except as otherwise indicated below, we believe that all persons
named in the table have sole voting and investment power with
respect to shares beneficially owned by them. All share ownership
figures include shares issuable upon exercise of options or
warrants exercisable within 60 days of May 30, 2018, which are
deemed outstanding and beneficially owned by such person for
purposes of computing his or her percentage ownership, but not for
purposes of computing the percentage ownership of any other person.
As of May 30, 2018 we had 21,356,069 shares of common stock
outstanding. For each individual and group included in the table
below, percentage ownership is calculated by dividing the number of
shares beneficially owned by such person or group by the sum of the
21,356,069 shares of common stock outstanding on May 30, 2018,
plus the number of shares of common stock that such person or group
had the right to acquire within 60 days after May 30,
2018.
|
Name of Beneficial Owner
|
|
Number of Shares Beneficially Owned
|
|
|
Percentage
Ownership
|
|
|
Executive Officers & Directors (1)
|
|
|
|
|
|
|
|
Stephan Wallach, Chairman and Chief Executive
Officer
|
|
|
14,127,811
|
(2)
|
|
|
65.8
|
%
|
|
David Briskie, President, Chief Financial Officer and
Director
|
|
|
920,457
|
(3)
|
|
|
4.2
|
%
|
|
Michelle Wallach, Chief Operating Officer and
Director
|
|
|
14,125,000
|
(2)
|
|
|
65.8
|
%
|
|
Richard Renton, Director
|
|
|
25,603
|
(4)
|
|
|
*
|
|
|
William Thompson, Director
|
|
|
12,000
|
(5)
|
|
|
*
|
|
|
Paul Sallwasser, Director
|
|
|
104,042
|
(6)
|
|
|
*
|
|
|
Kevin Allodi, Director
|
|
|
31,490
|
(7)
|
|
|
*
|
|
|
All Executive Officers & Directors, as a group (7
persons)
|
|
|
15,346,403
|
|
|
|
69.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders owning 5% or more
|
|
|
|
|
|
|
|
|
|
Carl Grover
|
|
|
2,422,945
|
(8)
|
|
|
9.99
|
%
|
*less than 1%
|
(1)
|
Unless
otherwise set forth below, the mailing address of Executive
Officers, Directors and 5% or greater holders is c/o Youngevity
International, Inc., 2400 Boswell Road, Chula Vista, California
91914.
|
|
(2)
|
Mr.
Stephan Wallach, our Chief Executive Officer, owns 14,000,000
shares of common stock through joint ownership with his wife,
Michelle Wallach, with whom he shares voting and dispositive
control. Mr. Wallach also owns 2,811 shares and options to purchase
125,000 shares of common stock which are exercisable within 60 days
of May 30, 2018 and are included in the number of shares
beneficially owned by him and Ms. Wallach also owns options to
purchase 125,000 shares of common stock which are exercisable
within 60 days of May 30, 2018 and are included in the number of
shares beneficially owned by her.
|
|
(3)
|
Mr. David Briskie, our President and Chief
Financial Officer, owns 170,429 shares of common stock, and
beneficially owns 100,028 shares of common stock owned by Brisk
Investments, LP, 250,000 shares of common stock owned by Brisk
Management, LLC. Mr. Briskie also owns options to purchase 400,000
shares of common stocks that are exercisable within 60 days of May
30, 2018 and are included in the number of shares beneficially
owned by him. Does not include 250,000 restricted stock units
issued to Mr. Briskie in August 2017, of which each unit represents
a contingent right to receive one share of common stock,
vesting as follows: (i) Year 3 - 25,000 shares; (ii) Year 4
– 37,500 shares; (iii) Year 5 - 125,000 shares; and (iv) Year
6 – 62,500 shares; provided that Mr. Briskie continues to
serve as an executive officer or otherwise is not terminated for
cause prior to such dates.
|
|
(4)
|
Mr. Renton is a director of the Company, owns
4,242 shares of common stock and 9,374 shares of common stock
through joint ownership
with his wife, Roxanna Renton, with whom he shares voting and dispositive
control. Mr. Renton also owns 9,500 options to purchase common
stock and 2,487 options
to purchase common stock held in joint ownership with his wife,
Roxanna Renton which are exercisable within 60 days of May 30,
2018.
|
|
(5)
|
Mr.
Thompson is a director of the Company, owns 12,000 options to
purchase common stock which are exercisable within 60 days of May
30, 2018 and are included in the number of shares beneficially
owned by him.
|
|
(6)
|
Mr.
Sallwasser is a director of the Company and owns a 2014 Note in the
principal amount of $75,000 convertible into 10,714 shares of
common stock and a 2014 Warrant exercisable for 14,673 shares of
common stock. Mr. Sallwasser also owns three 2017 Warrant’s
exercisable for 6,262 shares of common stock. He also owns 67,393
shares of common stock, which includes 9,264 shares from the
conversion of his 2017 Notes to common stock and an option to
purchase 5,000 shares of common stock.
|
|
(7)
|
Mr.
Allodi is a director of the Company and owns 13,888 shares of
common stock directly and 12,602 shares of common stock through
joint ownership with his wife Nancy Larkin Allodi. Mr. Allodi also
owns an option to purchase 5,000 shares of common
stock.
|
|
(8)
|
Share
ownership is based on information contained in a Schedule 13D/A
filed with the SEC on March 3, 2017, as updated for Mr.
Grover’s 2017 Note Conversion. Mr. Grover is the sole
beneficial owner of 2,422,945 shares of common stock. Mr. Grover
owns a 2014 Note in the principal amount of $4,000,000 convertible
into 571,428 shares of common stock and a 2014 Warrant exercisable
for 782,602 shares of common stock. Mr. Grover also owns a 2015
Note in the principal amount of $3,000,000 convertible into 428,571
shares of common stock and a 2015 Warrant exercisable for 200,000
shares of common stock. Mr. Grover also owns 2017 Warrants
exercisable for 735,030 shares of common stock. He also owns
1,379,795 shares of common stock which includes 1,122,233 shares
from the conversion of his 2017 Notes to common stock. Mr. Grover
has a contractual agreement with us that limits his exercise of
warrants and conversion of notes such that his beneficial ownership
of our equity securities to no more than 9.99% of the voting power
of the Company at any one time and therefore his beneficial
ownership does not include the shares of common stock issuable upon
conversion of notes or exercise or warrants owned by Mr. Grover if
such conversion or exercise would cause his beneficial ownership to
exceed 9.99% of our outstanding shares of common stock. Mr.
Grover’s address is 1010 S. Ocean Blvd., Apt 1017, Pompano
Beach, FL 33062.
|
NO DISSENTERS’ RIGHTS
The
corporate action described in this Proxy Statement will not afford
stockholders the opportunity to dissent from the actions described
herein or to receive an agreed or judicially appraised value for
their shares.
TRANSACTIONS WITH RELATED PERSONS, PROMOTERS AND CERTAIN CONTROL
PERSONS
The
following is a summary of transactions since January 1, 2016 to
which we have been a party in which the amount involved exceeded
$120,000 and in which any of our executive officers, directors or
beneficial holders of more than 5% of our capital stock have or
will have a direct or indirect interest, other than compensation
arrangements which are described in the sections of this Proxy
Statement.
2400 Boswell, LLC
2400
Boswell, LLC (“2400 Boswell”) is the owner and lessor
of the building occupied by us for our corporate office and
warehouse in Chula Vista, CA. As of December 31, 2012, an immediate
family member of a greater than 5% shareholder of us was the single
member of 2400 Boswell and we were co-guarantor of the 2400 Boswell
mortgage on the leased building. During 2013 we acquired 2400
Boswell LLC for $248,000 in cash, $334,000 of debt forgiveness and
accrued interest, and a promissory note of approximately $393,000,
payable in equal payments over 5 years and bore interest at 5.00%,
this note was satisfied during our first quarter of 2018. We
assumed the remaining long-term mortgage of $3,625,000, payable
over 25 years at an interest rate of 5.75%.
Richard Renton
Mr.
Richard Renton is a member of the Board of Directors and owns and
operates WVNP, Inc., a supplier of certain inventory items sold by
us. We made purchases of approximately $126,000 and $126,000
from
WVNP Inc., for the years ended December 31, 2017 and 2016,
respectively. In addition, Mr. Renton is also a distributor of ours
and was paid distributor commissions for the years ended December
31, 2017 and 2016 of approximately $398,000 and $457,000
respectively.
Paul Sallwasser
Mr.
Paul Sallwasser is a member of the Board of Directors and owns a
2014 Note in the principal amount of $75,000 convertible into
10,714 shares of common stock and a 2014 Warrant exercisable for
14,673 shares of common stock. Mr. Sallwasser acquired in the 2017
Private Placement a 2017 Note in the principal amount of $37,615
convertible into 8,177 shares of common stock and a 2017 Warrant
exercisable for 5,719 shares of common stock. Mr. Sallwasser also
acquired in the 2017 Private Placement in exchange for the 2015
Note he owned, a 2017 Note in the principal amount of $5,000
convertible into 1,087 shares of common stock and a 2017 Warrant
exercisable for 543 shares of common stock and an option to
purchase 5,000 shares of common stock that are immediately
exercisable. On March 29, 2018, we completed our Series B
Convertible Stock Offering, whereby in accordance with the terms of
the 2017 Notes, the 2017 Notes automatically converted into shares
of common stock upon us raising a minimum of $3,000,000 in
subsequent offerings. As a result, Mr. Sallwasser was issued 9,264
shares of common stock from the conversion of the 2017
Notes.
Carl Grover
Mr.
Carl Grover is the beneficial owner of in excess of five percent
(5%) of our outstanding common shares, is the sole beneficial owner
of 2,354,492 shares of common stock. Mr. Grover owns a 2014 Note in
the principal amount of $4,000,000 convertible into 571,428 shares
of common stock and a 2014 Warrant exercisable for 782,602 shares
of common stock. Mr. Grover also owns a 2015 Note in the principal
amount of $3,000,000 convertible into 428,571 shares of common
stock and a 2015 Warrant exercisable for 200,000 shares of common
stock. Mr. Grover acquired two 2017 Notes in the aggregate
principal amount of $5,162,273 convertible into 1,122,233 shares of
common stock and two 2017 Warrants exercisable for 735,030 shares
of common stock in the 2017 Private Placement. On March 29, 2018,
we completed our Series B Convertible Stock Offering, whereby in
accordance with the terms of the 2017 Notes, the 2017 Notes
automatically converted into shares of common stock upon us raising
a minimum of $3,000,000 in subsequent offerings. As a result, Mr.
Grover was issued 1,122,233 shares of common stock from the
conversion of the 2017 Notes.
Other Relationship Transactions
Hernandez, Hernandez, Export Y Company
Our
coffee segment, CLR Roasters (“CLR”), is associated
with Hernandez, Hernandez, Export Y Company
(“H&H”), a Nicaragua company, through sourcing
arrangements to procure Nicaraguan green coffee beans and in March
2014 as part of the Siles Plantation Family Group S.A.
(“Siles”) acquisition, CLR engaged the owners of
H&H as employees to manage Siles. We made purchases of
approximately $10,394,000 and $8,810,000 from this supplier for the
years ended December 31, 2017 and 2016, respectively.
In
addition, CLR sold approximately $6,349,000 and $2,637,000 for the
years ended December 31, 2017 and 2016, respectively, of green
coffee beans to H&H Coffee Group Export, a Florida based
company which is affiliated with H&H.
In
March 2017, CLR entered a settlement agreement and release with
H&H Coffee Group Export pursuant to which it was agreed that
$150,000 owed to H&H Coffee Group Export for services that had
been rendered would be settled by the issuance of common stock. In
May 2017, we issued to H&H Coffee Group Export 27,500 shares of
common stock in accordance with this agreement.
In
May 2017, CLR entered into a settlement agreement with Alain Piedra
Hernandez, one of the owners of H&H and the operating manager
of Siles, who was issued a non-qualified stock option for the
purchase of 75,000 shares of our common stock at a price of $2.00
with an expiration date of three years, in lieu of an obligation
due from CLR to H&H as relates to a Sourcing and Supply
Agreement with H&H. During the period ended September 30, 2017
we replaced the non-qualified stock option and issued a warrant
agreement with the same terms, as remains outstanding. There was no
financial impact related to the cancellation of the option and the
issuance of the warrant.
H&H
Coffee Group Export also participated in our Series B Offering and
purchased 126,316 shares of Series B Convertible Preferred Stock at
$9.50 per share for an aggregate investment of
$1,200,000.
Related Party Transaction Policy and Procedures
Pursuant
to our Related Party Transaction and Procedures, our executive
officers, directors, and principal stockholders, including their
immediate family members and affiliates, are prohibited from
entering into a related party transaction with us without the prior
consent of our Audit Committee or our independent directors. Any
request for us to enter into a transaction with an executive
officer, director, principal stockholder, or any of such
persons’ immediate family members or affiliates, must first
be presented to our Audit Committee for review, consideration and
approval. In approving or rejecting the proposed agreement, our
Audit Committee will consider the relevant facts and circumstances
available and deemed relevant, including, but not limited, to the
risks, costs and benefits to us, the terms of the transaction, the
availability of other sources for comparable services or products,
and, if applicable, the impact on a director’s independence.
Our Audit Committee approves only those agreements that, in light
of known circumstances, are in, or are not inconsistent with, our
best interests, as our Audit Committee determines in the good faith
exercise of its discretion.
OTHER MATTERS
As of
the date of this Proxy Statement, the Board of Directors of YGYI
knows of no other matters to be presented for stockholder action at
the 2018 Annual Meeting. However, other matters may properly come
before the 2018 Annual Meeting or any adjournment or postponement
thereof. If any other matter is properly brought before the 2018
Annual Meeting for action by the stockholders, proxies in the
enclosed form returned to YGYI will be voted in accordance with the
recommendation of the Board of Directors.
ANNUAL REPORT/FORM 10-K
Our
2017 Annual Report to our stockholders is being mailed to certain
stockholders concurrently with this Proxy Statement. Copies of our
Annual Report on Form 10-K as filed with the SEC and any amendments
thereto may be obtained without charge by writing to Youngevity
International, Inc., 2400 Boswell Road, Chula Vista, California
91914, Attention: Corporate Secretary. A complimentary copy may
also be obtained at the internet website maintained by the SEC at
www.sec.gov, and by
visiting our internet website at www.ygyi.com.
NOTICE REGARDING DELIVERY OF STOCKHOLDER DOCUMENTS
(“HOUSEHOLDING” INFORMATION)
The SEC
has adopted rules that permit companies and intermediaries (e.g.,
brokers) to satisfy the delivery requirements for Notices of
Internet Availability of Proxy Materials, proxy statements and
annual reports by delivering a single copy of these materials to an
address shared by two or more YGYI stockholders. This process,
which is commonly referred to as “householding,”
potentially means extra convenience for stockholders and cost
savings for companies and intermediaries. A number of brokers and
other intermediaries with account holders who are our stockholders
may be householding our stockholder materials, including this proxy
statement. In that event, a single proxy statement will be
delivered to multiple stockholders sharing an address unless
contrary instructions have been received from the affected
stockholders. Once you have received notice from your broker or
other intermediary that it will be householding communications to
your address, householding will continue until you are notified
otherwise or until you revoke your consent, which is deemed to be
given unless you inform the broker or other intermediary otherwise
when you receive or received the original notice of householding.
If, at any time, you no longer wish to participate in householding
and would prefer to receive separate Proxy Materials, please notify
your broker or other intermediary to discontinue householding and
direct your written request to receive a separate proxy statement
to us at: Youngevity International, Inc., Attention: Corporate
Secretary, 2400 Boswell Road, Chula Vista, California 91914 or by
calling us at (619) 934-3980. Stockholders who currently receive
multiple copies of the proxy statement at their address and would
like to request householding of their communications should contact
their broker or other intermediary.
STOCKHOLDER PROPOSALS FOR THE 2019 ANNUAL MEETING
Stockholders who
intend to present proposals at the 2019 Annual Meeting of Stockholders under
SEC Rule 14a-8 must ensure that such proposals are received by the
Corporate Secretary of our company not later than February 8, 2019.
Such proposals must meet the requirements of the SEC to be eligible
for inclusion in our 2019 proxy
materials.
All
proposals should be addressed to the Corporate Secretary,
Youngevity International, Inc., 2400 Boswell Road, Chula Vista,
California 91914.
|
|
By
Order of the Board of Directors
|
|
|
|
|
|
/s/ Stephan
Wallach
|
|
|
Stephan
Wallach
Chairman
of the Board and CEO
|
|
Chula
Vista, California
June 8,
2018
|
|

|
YOUNGEVITY INTERNATIONAL, INC.
2400 Boswell Road
Chula Vista, California 91914
|
VOTE BY INTERNET - www.proxyvote.com
Use the
Internet to transmit your voting instructions and for electronic
delivery of information up until 11:59 p.m. Eastern Daylight Time
on July 22, 2018. Have your proxy card in hand when you access the
web site and follow the instructions to obtain your records and to
create an electronic voting instruction form.
|
|
|
|
ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS
If you
would like to reduce the costs incurred by our company in mailing
proxy materials, you can consent to receiving all future proxy
statements, proxy cards and annual reports electronically via
e-mail or the Internet. To sign up for electronic delivery, please
follow the instructions above to vote using the Internet and, when
prompted, indicate that you agree to receive or access proxy
materials electronically in future years.
|
|
|
|
|
|
VOTE BY PHONE - 1-800-690-6903
Use any
touch-tone telephone to transmit your voting instructions. Vote by
11:59 p.m. Eastern Daylight Time on 07/22/2018. Have
your proxy card in hand when you call and then follow the
instructions.
|
|
|
|
|
|
VOTE BY MAIL
Mark,
sign and date your proxy card and return it in the postage-paid
envelope we have provided or return it to Vote Processing, c/o
Broadridge, 51 Mercedes Way, Edgewood, NY 11717.
|
|
TO
VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:
☒
|
KEEP
THIS PORTION FOR YOUR RECORDS
|
|
—
— — — — — — — —
— — — — — — — —
— — — — — — — —
— — — — — — — —
— — — — — — — —
— — — — — — — —
—
|
|
|
THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.
|
DETACH
AND RETURN THIS PORTION ONLY
|
|
|
|
|
|
|
For
|
Withhold
|
For All
|
To
withhold authority to vote for any individual
|
|
|
All
|
All
|
Except
|
nominee(s),
mark “For All Except” and write the
|
|
The
Board of Directors recommends you vote FOR the
following:
|
|
|
|
number(s)
of the nominee(s) on the line below.
|
|
|
|
|
|
|
|
|
|
|
|
1.
|
Proposal
1—Election of Directors
|
☐
|
☐
|
☐
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nominees:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
01
Stephan
Wallach
|
02
David
Briskie
|
03
Michelle
Wallach
|
04
Richard
Renton
|
05
William
06 Kevin
07 Paul
Thompson
Allodi
Sallwasser
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors recommends you vote FOR the following
Proposal 2:
|
|
For
|
Against
|
Abstain
|
|
|
|
|
|
|
|
|
|
|
2.
|
To
ratify the appointment of Mayer Hoffman McCann P.C. as our
independent registered public accounting firm for our fiscal year
ending on December 31, 2018.
|
|
☐
|
☐
|
☐
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NOTE: To transact such other business as may properly come
before the meeting or any adjournments or postponements of the
meeting.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Please
sign exactly as your name(s) appear(s) hereon. When signing
as
attorney,
executor, administrator, or other fiduciary, please give
full
title
as such. Joint owners should each sign personally. All holders
must
sign.
If a corporation or partnership, please sign in full corporate
or
partnership
name, by authorized officer.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Signature
[PLEASE SIGN WITHIN BOX]
|
Date
|
|
Signature
(Joint Owners)
|
Date
|
|
|
Important Notice Regarding the Availability of Proxy Materials for
the Annual Meeting: The proxy
materials & Proxy Statement, and Form 10-K are available
at www.voteproxy.com
|
|
|
|
|
—
— — — — — — — —
— — — — — — — —
— — — — — — — —
— — — — — — — —
— — — — — — — —
— — — — — — — —
—
|
|
|
|
|
|
YOUNGEVITY INTERNATIONAL, INC.
2018 Annual Meeting of Stockholders
July 23, 2018 9:00 a.m. (PDT)
This proxy is solicited by the Board of Directors
|
|
|
|
The
undersigned stockholder hereby appoints Stephan Wallach and David
Briskie, or either of them, as proxies, each with full power of
substitution, hereby authorizes them to represent and to vote, as
designated on the reverse side of this ballot, all of the shares of
common stock of YOUNGEVITY INTERNATIONAL, INC. that the undersigned
is entitled to vote at the Annual Meeting of Stockholders to be
held at 9:00 a.m., PDT time, on July 23, 2018, at the offices of
the Company, 2400 Boswell Road, Chula Vista, California 91914, and
any adjournment or postponement thereof.
|
|
|
|
This
proxy, when properly executed, will be voted in the manner directed
herein. If no such direction is made, this proxy will be voted in
accordance with the Board of Directors'
recommendations.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continued and to be signed on reverse side
|